Speaker illustration

Mr Yeshai Schary

Tel Aviv University, Tel Aviv (Israel)

CRISPR-Cas9-based gene editing of human mesenchymal stromal cells to improve the outcome of cell therapy

Event: ESC Congress 2020

Topic: Gene Therapy, Cell Therapy

Session: Basic Science Cardiac ePosters

Thumbnail